Synthesis of [3H] vardenafil, Levitra®, using a new labeling technique

Journal of Labelled Compounds and Radiopharmaceuticals

Volumn 46, Issue 13, 2003, Pages 1241-1247

  Pleiss, U ^a  

^a BAYER PHARMA AG   (Germany)

Author keywords

Complex tritide; Levitra ; PDE V inhibitor; Tritium labeling technique

Indexed keywords

AMIDES;

% REDUCTIONS; COMPLEX TRITIDE; LABELING TECHNIQUES; LEVITRUM®; ORALLY ACTIVE; PHOSPHODIESTERASE TYPE V INHIBITOR; PHOSPHODIESTERASES; TRITIDES; TRITIUM LABELING TECHNIQUE; VARDENAFIL;

TRITIUM;

AMIDE; LITHIUM ALUMINUM TRITIDE; PHOSPHODIESTERASE INHIBITOR; TRITIUM; UNCLASSIFIED DRUG; VARDENAFIL;

ARTICLE; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; COMPLEX FORMATION; DECOMPOSITION; HYDROGENATION; ISOTOPE LABELING; PURIFICATION; RADIOCHEMISTRY; REDUCTION; SYNTHESIS;

TRITIUM;

EID: 0344119641     PISSN: 03624803     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlcr.782     Document Type: Article

References (3)

1. Bischoff E, Niewöhner U, Es Sayed M, Schenke T, Schlemmer K-H. J Urol 2000; 165: 1316.
2. Andres H, Morimoto H, Williams PG. J Chem Soc, Chem Commun 1990; 627-628.
3. Pleiss U. In Synthesis and Applications of Isotopically Labelled Compounds, Proceedings of the 4th International Symposium, Toronto, Canada, Buncel E, Kabalka, GW. (eds). Elsevier: Amsterdam, 1991; 34-39.